Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2021-07-07
2022-06-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of Neurofeedback to Enhance Attention After Brain Injury
NCT03324178
Assessment of Attentional and Executive Disorders in Multiple Sclerosis Using Techniques of Virtual Reality
NCT01805336
Cognitive Impairment in Pediatric Onset Multiple Sclerosis
NCT03190902
Enhancing Behavior and Brain Response to Visual Targets Using a Computer Game
NCT02118649
Eye-tracking Working Memory Training in Children and Youth With Severe Cerebral Palsy
NCT06918379
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
X fragile syndrome patients
Quantitative attention evaluation criteria in intellectual disability
Quantitative interactive attention evaluation tests by using games on touchscreen and or eye tracking (oculometer)
Angelman syndrome patients
Quantitative attention evaluation criteria in intellectual disability
Quantitative interactive attention evaluation tests by using games on touchscreen and or eye tracking (oculometer)
Rett syndrome patients
Quantitative attention evaluation criteria in intellectual disability
Quantitative interactive attention evaluation tests by using games on touchscreen and or eye tracking (oculometer)
Patients with other genetic rare syndromes with intellectual d
Quantitative attention evaluation criteria in intellectual disability
Quantitative interactive attention evaluation tests by using games on touchscreen and or eye tracking (oculometer)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Quantitative attention evaluation criteria in intellectual disability
Quantitative interactive attention evaluation tests by using games on touchscreen and or eye tracking (oculometer)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Minor patients 6 years old or more (age corresponding to the end of regression period observed in Rett patients) or major protected patients
3. Patients with more or less severe intellectual disability from various causes including Fragile X syndrome, Rett syndrome, Angelman syndrome and other etiologies of intellectual disabilities and intellectual disabilities without identified etiology
4. Affiliation to a social security system own or affiliated (excluding AME)
5. Presence of parents or legal representative
6. Informed consent signed by parents or legal representative
Exclusion Criteria
2. Uncontrolled seizure disorder despite treatment
6 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Plateforme PRISME
UNKNOWN
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
CHARLES Perrine, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique - Hôpitaux de Paris
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital La Pitié-Salpêtrière
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2018-A00686-49
Identifier Type: REGISTRY
Identifier Source: secondary_id
K180106J
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.